search
Search
News

News

News

ABOUT US

图片名称

News search

Click to query
Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

View details >>

12

2023

/

10

Qilu Pharmaceutical launched the first innovative drug in China

Qilu Pharmaceutical launched the first innovative drug in China

View details >>

01

2023

/

09

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

View details >>

04

2023

/

04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

View details >>

19

2022

/

12

Qilu Pharmaceutical ranked 5th among China's top 100 list

Qilu Pharmaceutical ranked 5th among China's top 100 list

View details >>

18

2022

/

07

The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

View details >>

15

2022

/

06

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

View details >>

02

2021

/

08

< 1234...18 >
Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.

Tel: +86-531-83127705, 83127704, 83127706, 83127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

E mail：export@qilu-pharma.com, FDF@qilu-pharma.com

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Powered by www.300.cn

监督举报

亲爱的合作伙伴：

欢迎举报以下行为！

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话：0531-83126898/55820713/83126871

举报邮箱：qljc@qilu-pharma.com

收信地址：山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线

0531-55820865